La cadena de opciones muestra datos clave de las opciones de acciones de China SXT Pharmaceuticals a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para China SXT Pharmaceuticals..

China SXT Pharmaceuticals (NASDAQ:SXTC) Bolsa, Cadena de Opciones

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals Inc

WIIM

BURU

Nuburu shares are trading higher after the company said it believes its retained intellectual property,  personnel and relationships will allow it to continue operating in the laser technology field, with a focus on defense, semiconductor and industrial manufacturing applications.

SNCR

Synchronoss Technologies shares are trading higher after the company reported better-than-expected Q4 earnings and sales.

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Agenus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) from Neutral to Neutral.

News

Reiteration

Analyst Ratings

AGEN

HC Wainwright & Co. Reiterates Neutral on Agenusto Neutral

Rosenblatt analyst Mike Genovese maintains Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) with a Neutral and lowers the price target from $79 to $73.

Price Target

CIEN

Rosenblatt Maintains Neutral on Ciena, Lowers Price Target to $73

IRBT

iRobot shares are trading lower after the company disclosed substantial doubt about its ability to continue as a going concern.

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Geron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) from Neutral to Neutral.

GERN

HC Wainwright & Co. Reiterates Neutral on Geronto Neutral

Heinz Launched Dip For Potato Chips, Same Unmistakable Ketchup, New Way To Enjoy

SFIX

Stitch Fix shares are trading higher following strong Q2 earnings and upbeat Q3 guidance.

GRPN

Groupon shares are trading higher after the company reported better-than-expected Q4 revenue results.

Needham analyst Ryan Koontz maintains Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) with a Buy and lowers the price target from $95 to $90.

Needham Maintains Buy on Ciena, Lowers Price Target to $90

Rosenblatt analyst Blair Abernethy upgrades Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) from Neutral to Buy and announces $77 price target.

Upgrades

RBRK

Rosenblatt Upgrades Rubrik to Buy, Announces $77 Price Target

TSLA

Tesla shares are trading higher after CEO Elon Musk on social media announced plans to double US vehicle production within two years.

Whitestone REIT Announced That It Has Signed A Lease With The Picklr To Open A 20,909-square-foot Location At Terravita Marketplace In Scottsdale, Arizona

STEC

Santech Holdings Regains NASDAQ Compliance, Closes Chapter On Minimum Bid Price Violation

TLRY

Tilray Beverages Announced The Distribution Expansion For Runner's High Brewing, Its Non-alcoholic Craft Beer Brand, Across 4,500 New Distribution Points

INTC: 9% &#x7C; <a href="https://www.benzinga.com//node/44271204">TSMC Proposes Joint Venture With Nvidia, AMD And Broadcom To Operate Intel's Factories: Report</a>
&nbsp;
GRPN: 27% &#x7C; <a href="https://www.benzinga.com//node/44262868">Groupon shares are trading higher after the company reported better-than-expected Q4 revenue results.</a>
&nbsp;
SFIX: 24% &#x7C; <a href="https://www.benzinga.com//node/44262293">Stitch Fix shares are trading higher following strong Q2 earnings and upbeat Q3 guidance.</a>

Movers

Trading Ideas

INTC

Market-Moving News for March 12th

Intel shares are trading higher following a report suggesting TSMC pitched a joint venture to Nvidia, AMD, Broadcom and Qualcomm to operate Intel's factories.

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Immunocore Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) with a Buy and maintains $100 price target.

IMCR

HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

Q1 2025 Guidance
Given the prevailing uncertainty in NIH funding and academic research purchasing, along with normal seasonality, the Company expects Q1 2025 revenues of $19 million to $21 million and gross margin in the 56% to 58% range.

Guidance

HBIO

Harvard Bioscience Expects Q1 Revenue Of $19M-$21M Vs $22.95M Est

Piper Sandler analyst Derek Podhaizer assumes Atlas Energy Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NYSE">AESI</a>) with a Overweight rating and announces Price Target of $22.

Initiation

AESI

Piper Sandler Assumes Atlas Energy Solutions at Overweight, Announces Price Target of $22

Press Releases

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

Comments

China SXT Pharmaceuticals

China SXT Pharmaceuticals (SXTC) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL